BioSpace News Archive

INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, announced that the Medicines and Healthcare products Regulatory Agency (MHRA; the UK equivalent of the FDA) has given approval to i

Regence today announced a new partnership with Healthmap Solutions—a growing national Population Health Management company with a flagship Kidney Health Management (KHM) program—to improve care and outcomes for Regence members with Chronic Kidney Disease (CKD) and End Stage Renal Disease (ESRD).

EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2), (the “Company” or “EXM”), is pleased to announce that it has entered into a letter of intent (“LOI”) with Econnabis SAS, an operating subsidiary of Plena Global Holdings Inc. (“Plena Global”), a large-scale producer and supplier of medical grade cannabis ingredients, to supply EXM’s proposed Portugal refinery with up to 200 kg of GMP compliant THC Distillate.

Welldoc® , revolutionizing digital health with the first FDA-cleared Software as a Medical Device (SaMD) for diabetes, today announced the expansion of an agreement with Mass General Brigham (formerly Partners HealthCare). After conducting a 2-year program of Quality Improvement (QI) research with the Ambulatory Practice of the Future

Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that Raul Elizalde and Caroline Heinz , co-CEOs of its subsidiary HempMeds® , have been invi

Glytec, the only provider of insulin management software across the continuum of care, announced today that healthcare providers from five separate health systems will present studies on the transformative effects of implementing its eGlycemic Management System (eGMS) during the 2020 Diabetes Technology Society (DTS) Virtual Hospital Poster Session.

Sinovac and Butantan J oin Efforts to Advance the Clinical Development of An Inactivated Vaccine for COVID-19 to Phase III

Latest innovation helps people with diabetes easily enable telehealth connectivity by linking directly into Apple Health® for effortless sharing with telehealth platforms like Teledoc and Doctor on Demand. [11-June-2020] MALVERN, Pa. , June 11, 2020 /PRNewswire/ -- LifeScan, a world leader in blood glucose monitoring and maker of the iconic OneTouch ® brand, today an

June 11, 2020 13:20 UTC Novo Nordisk acquires Corvidia for $2.1B with an upfront payment of $725M in cash Sofinnova Partners co-founded Corvidia as its sole seed financial investor in 2015 with serial entrepreneur Michael Davidson PARIS--( BUSINESS WIRE )-- Sofinnova Partners , a leading European life sciences venture capital firm based in Paris, London and Milan, announced today the sale of its portfolio company Corvidia Therapeutics to Novo Nordisk, for $2.1 bi

MiRus is pleased to announce that it received FDA 510(k) clearance for its 3DR™ (Randomized) Printed Lumbar Interbody Fusion System which consists of the CALLISTO 3DR™ PLIF, HYPERION 3DR™ TLIF, CALYPSO 3DR™ LLIF and the ANTARES 3DR™ ALIF.